Elsevier

Neuroscience Letters

Volume 78, Issue 2, 22 July 1987, Pages 233-238
Neuroscience Letters

Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain

https://doi.org/10.1016/0304-3940(87)90639-2Get rights and content

Abstract

γ-Aminobutyric acid (GABA), glutamate and serotonin (5-HT), along with its major metabolite, 5-hydroxyindoleacetic acid (5-HIAA), have been measured in 4 brain regions taken post-mortem from patients with Huntington's disease and from control subjects. GABA was found to be significantly reduced, not only in the basal ganglia, but also in the cortex and hippocampus. Glutamate was also reduced in all regions except the pallidum, and thus was unrelated to the GABA deficit which was greatest in this area. 5-HT and 5-HIAA were significantly increased in all areas except the hippocampus.

References (22)

  • E.D. Bird et al.

    Huntington's chorea - post-mortem measurement of glutamic acid decarboxylase, choline acetyl-transferase and dopamine in basal ganglia

    Brain

    (1974)
  • Cited by (69)

    • Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea

      2011, Parkinsonism and Related Disorders
      Citation Excerpt :

      Such striatal atrophy would inevitably result in an increase in the density of 5-HT axon varicosities, unless a significant loss of such terminals occurs. Striatal atrophy could also explain the above-normal level of striatal 5-HT noted in post-mortem biochemical studies of HD [15,30]. In the HD cases we examined, 5-HT innervation was increased in the putamen and the caudate nucleus but relatively unaltered in the nucleus accumbens.

    • Huntington's disease: Pathogenesis to animal models

      2010, Pharmacological Reports
      Citation Excerpt :

      Disruptions in GABA systems are not limited to the striatum. Reynolds and Pearson [94] have shown decreased GABA levels in the hippocampus and cerebral cortex as well as reduced levels of the synaptic enzyme GAD throughout the brain. Different neuronal circuits expressing various pathways are shown in Figure 3.

    • Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease

      2008, Neurobiology of Disease
      Citation Excerpt :

      These reports are in contrast to those reported in human postmortem HD brains, however. Specifically, several groups have found that 5-HT levels are elevated in blood and brains of HD patients (Reynolds and Pearson 1987; Kish et al., 1987; Beal et al., 1990). One possibility is that striatal atrophy that occurs in HD may account for these findings.

    View all citing articles on Scopus
    View full text